Notable Upgrades: Exact Sciences (EXAS), PTC Therapeutics (PTCT), Amazon.com (AMZN), Intel (INTC), Applied Materials (AMAT)

Analysts at Goldman Sachs (GS) lifted their price target on shares of Exact Sciences Corporation (EXAS) to $32 from $25 in a report released on Thursday. The firm currently has a ‘Buy’ rating on the stock.

Exact Sciences Corporation shares have surged 132% over the past 52 weeks, while the S&P 500 has gained 11.23% in the same period.

Shares of Exact Sciences gained 4.77% to $27.25 in recent trading.

Investment analysts at Citigroup (C) initiated coverage on shares of PTC Therapeutics, Inc. (PTCT) in a note issued to investors on Thursday. The firm set a ‘Buy’ rating and a $81.00 price target on the stock.

PTC Therapeutics shares have spiked 192% over the past 52 weeks, while the S&P 500 has gained 11.23% in the same period.

Shares of PTC Therapeutics, Inc. gained 5.27% to $53.56 in recent trading.

Piper Jaffray’s Gene Munster names Amazon.com Inc. (AMZN) as his ‘Top Large Cap Pick’ for 2015. The analyst reiterated an ‘Overweight’ rating and price target of $400.

AMZN has a median Wall Street price target of $350.00 with a high target of $450.00.

In the past 52 weeks, shares of Seattle, Washington-based company have traded between a low of $284.00 and a high of $408.06 and are now at $296.20. Shares are down 22.90% year-over-year and 25.05% year-to-date.

Citigroup (C) analysts are out with a report this morning initiating coverage of Intel Corporation (INTC) with a ‘Neutral’ rating and $35 price target. Shares of Intel are trading up more than 1.50% to $36.82 in Thursday’s session.

Citigroup (C) adds Applied Materials, Inc. (AMAT) to ‘Focus List’ with $36.00, 12-month base case estimate.

Applied Materials shares were 1.74% higher to 24.87% in mid-day trading Thursday. The name is up 40.72% in the year to date, while the S&P 500 index has gained 11.23%.

Shares of Tetraphase Pharmaceuticals, Inc. (TTPH) are up 15% to $38.10 in mid-day trading, after the company had its price target raised to $40 from $26 at Cantor Fitzgerald. The firm currently has a ‘Buy’ rating on the stock. TTPH was also raised to $46 from $28 at Needham.

Tetraphase shares have surged 181% over the past 52 weeks, while the S&P 500 index has gained 11.23% in the same period.

OvaScience, Inc. (OVAS) price target has been raised from $23 to $56 by Leerink Partners analysts, according to a research note published on Thursday.┬áLeerink analysts maintained their ‘Outperform’ rating on the company.┬áThe new price target represents a potential upside of 17% from the name’s current pps. OVAS was also upgraded to ‘Outperform’ from ‘Neutral’ at Wedbush.

In the past 52 weeks, shares of OvaScience have traded between a low of $5.51 and a high of $49.94 and are now up 34% at $46.74. Ticker has gianed 410% year-to-date, compared with a 11.23% gain in the S&P 500.

Oracle Corporation (ORCL) price target has been raised from $48 to $50 by Canaccord Genuity analysts, according to a research note published on Thursday.

ORCL gained 8% to $44.51 in mid-day trading today. Approximately 29 million shares have already changed hands, compared to the stock’s average daily volume of 15.5 million shares.

About Ron Haruni 1036 Articles
Ron is the Co-Founder & Editor in Chief of Wall Street Pit. Web Site: Wall Street Pit

Be the first to comment

Leave a Reply

Your email address will not be published.


*